Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure
about
Pharmacogenetics of human ABC transporter ABCC11: new insights into apocrine gland growth and metabolite secretionLocalization of multidrug resistance-associated proteins along the blood-testis barrier in rat, macaque, and human testisDiagnosis of Human Axillary Osmidrosis by Genotyping of the Human ABCC11 Gene: Clinical Practice and Basic Scientific EvidenceRegulation of the Axillary Osmidrosis-Associated ABCC11 Protein Stability by N-Linked Glycosylation: Effect of Glucose ConditionMED23 in endocrinotherapy for breast cancerABCC11/MRP8 Expression in the Gastrointestinal Tract and a Novel Role for Pepsinogen Secretion.Dependence of deodorant usage on ABCC11 genotype: scope for personalized genetics in personal hygieneEradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survivalMembrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease.Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications.Pharmacogenetics and breast cancer management: current status and perspectives.Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant.Glutathione-conjugated sulfanylalkanols are substrates for ABCC11 and γ-glutamyl transferase 1: a potential new pathway for the formation of odorant precursors in the apocrine sweat gland.Earwax type and osmidrosis: prognostic factor for breast cancer?The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans.
P2860
Q21131244-066F145E-F213-405E-AAD6-90C2461B6FC1Q24338444-03FFAA34-EE4A-4FE2-A3BE-50B42F03BA3CQ26750757-2907320D-5178-484E-BD66-FA5BC1312385Q28550154-9102220F-0918-4792-B9DF-7112778E7A75Q33750787-6467BF0A-472E-441D-990D-05AA8E6B4A1CQ34184465-5EED0C8F-307D-48D3-8B60-2E41B2D04B6CQ34323000-B4497D3B-23E3-4322-B9F1-928289E19073Q35109273-B9A3EAD8-5235-4378-913A-9E66C338095CQ36576187-5FEBE71E-BA40-4EA7-9D77-E243026AE32BQ37629916-FF99F83B-CD63-4F61-A634-E5CA8F25A60FQ38050315-B4C75FE5-9481-4D76-8C0D-C926A30DAC5CQ38358816-FFBD142B-7CDA-4662-A041-6728A1DFD2F9Q38884180-F16B9029-EAA5-4F8F-9CE1-BBC251C33F1AQ39023265-C315423D-CFC2-40FB-B798-D69E7E64F0EBQ43573766-96D56A55-DBD5-4809-93FB-478F9F82FA56Q46422014-F8C0CA42-7A83-412B-A489-78F088EBA85E
P2860
Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Pharmacogenomics of human ABC ...... ancer and chemotherapy failure
@ast
Pharmacogenomics of human ABC ...... ancer and chemotherapy failure
@en
type
label
Pharmacogenomics of human ABC ...... ancer and chemotherapy failure
@ast
Pharmacogenomics of human ABC ...... ancer and chemotherapy failure
@en
prefLabel
Pharmacogenomics of human ABC ...... ancer and chemotherapy failure
@ast
Pharmacogenomics of human ABC ...... ancer and chemotherapy failure
@en
P2860
P921
P1476
Pharmacogenomics of human ABC ...... ancer and chemotherapy failure
@en
P2093
Toshihisa Ishikawa
P2860
P304
P356
10.2174/187152010794473975
P5008
P577
2010-10-01T00:00:00Z